Bluejay Diagnostics (BJDX) Total Liabilities (2020 - 2026)

Bluejay Diagnostics has disclosed Total Liabilities across 7 years of filings, most recently posting $1.4 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $1.4 million, changed 0.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (changed 0.41% YoY), and the FY2025 annual result was $1.1 million, up 23.28% from the prior year.
• Total Liabilities came in at $1.4 million for Q1 2026 at Bluejay Diagnostics, up from $1.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $927924.0 in Q4 2024.
• The 5-year median for Total Liabilities is $1.6 million (2022), against an average of $1.6 million.
• Peak annual rise in Total Liabilities reached 1241.6% in 2022, while the deepest fall reached 62.95% in 2022.
• Bluejay Diagnostics' Total Liabilities stood at $2.0 million in 2022, then decreased by 0.32% to $2.0 million in 2023, then slumped by 52.99% to $927924.0 in 2024, then advanced by 23.28% to $1.1 million in 2025, then increased by 23.9% to $1.4 million in 2026.
• The last three Total Liabilities figures came in at $1.4 million (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.